See also this year's filing and all EDGAR filings for this company.
PDF Report 0001595097_2018_Corbus_Pharmaceuticals_Holdings_Inc.pdf
Logs
Graph
Absolute values for 0001595097, Corbus Pharmaceuticals Holdings Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 65,504,730 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 1,432,655 |
| 3 | remainder_Assets | 40,776 |
| 4 | LiabilitiesCurrent | 8,204,675 |
| 5 | LiabilitiesNoncurrent | 375 |
| 6 | remainder_Liabilities | 989,550 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 8,964,046 |
| 9 | ResearchAndDevelopmentExpense | 26,038,965 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 2,440,195 |
| 12 | remainder_NetIncome | 141,204 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 66,978,161 |
| 1 | Liabilities | 9,194,600 |
| 2 | Expenses | 35,003,011 |
| 3 | Revenues | 2,440,195 |
| 4 | StockholdersEquity | 57,783,561 |
| 5 | NetIncome | -32,421,612 |
| 6 | ComprehensiveNetIncome | -32,421,612 |
| 7 | BaseVar | 56,878,586 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.46 |
| 9 | EconomicCapitalRatio | 3.33 |